Correlation Between Enliven Therapeutics and Ensysce Biosciences
Can any of the company-specific risk be diversified away by investing in both Enliven Therapeutics and Ensysce Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enliven Therapeutics and Ensysce Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enliven Therapeutics and Ensysce Biosciences, you can compare the effects of market volatilities on Enliven Therapeutics and Ensysce Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enliven Therapeutics with a short position of Ensysce Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enliven Therapeutics and Ensysce Biosciences.
Diversification Opportunities for Enliven Therapeutics and Ensysce Biosciences
0.04 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Enliven and Ensysce is 0.04. Overlapping area represents the amount of risk that can be diversified away by holding Enliven Therapeutics and Ensysce Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ensysce Biosciences and Enliven Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enliven Therapeutics are associated (or correlated) with Ensysce Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ensysce Biosciences has no effect on the direction of Enliven Therapeutics i.e., Enliven Therapeutics and Ensysce Biosciences go up and down completely randomly.
Pair Corralation between Enliven Therapeutics and Ensysce Biosciences
Given the investment horizon of 90 days Enliven Therapeutics is expected to generate 0.44 times more return on investment than Ensysce Biosciences. However, Enliven Therapeutics is 2.28 times less risky than Ensysce Biosciences. It trades about 0.04 of its potential returns per unit of risk. Ensysce Biosciences is currently generating about -0.02 per unit of risk. If you would invest 1,772 in Enliven Therapeutics on September 3, 2024 and sell it today you would earn a total of 666.00 from holding Enliven Therapeutics or generate 37.58% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Enliven Therapeutics vs. Ensysce Biosciences
Performance |
| Timeline |
| Enliven Therapeutics |
| Ensysce Biosciences |
Enliven Therapeutics and Ensysce Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Enliven Therapeutics and Ensysce Biosciences
The main advantage of trading using opposite Enliven Therapeutics and Ensysce Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enliven Therapeutics position performs unexpectedly, Ensysce Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ensysce Biosciences will offset losses from the drop in Ensysce Biosciences' long position.| Enliven Therapeutics vs. DiaMedica Therapeutics | Enliven Therapeutics vs. Lyra Therapeutics | Enliven Therapeutics vs. Centessa Pharmaceuticals PLC |
| Ensysce Biosciences vs. Zura Bio Limited | Ensysce Biosciences vs. Phio Pharmaceuticals Corp | Ensysce Biosciences vs. Sonnet Biotherapeutics Holdings | Ensysce Biosciences vs. 180 Life Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |